These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 36475473)
1. BioMatrix Versus Orsiro Stents for Coronary Artery Disease: A Multicenter, Randomized, Open-Label Study. Yoon CH; Kwun JS; Choi YJ; Park JJ; Kang SH; Kim SH; Suh JW; Youn TJ; Kim MK; Cha KS; Lee SH; Hong BK; Rha SW; Kang WC; Lee JH; Kim SH; Chae IH Circ Cardiovasc Interv; 2023 Jan; 16(1):e012307. PubMed ID: 36475473 [TBL] [Abstract][Full Text] [Related]
8. Unselected Use of Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent for Coronary Revascularization. Yamaji K; Zanchin T; Zanchin C; Stortecky S; Koskinas KC; Hunziker L; Praz F; Blöchlinger S; Moro C; Moschovitis A; Seiler C; Valgimigli M; Billinger M; Pilgrim T; Heg D; Windecker S; Räber L Circ Cardiovasc Interv; 2018 Sep; 11(9):e006741. PubMed ID: 30354590 [TBL] [Abstract][Full Text] [Related]
9. Biodegradable Polymer Versus Polymer-Free Ultrathin Sirolimus-Eluting Stents: Analysis of the Stent Arm Registry From the HOST-IDEA Randomized Trial. Han JK; Yang S; Hwang D; Park SH; Kang J; Yang HM; Park KW; Kang HJ; Koo BK; Cho JM; Cho J; Bang DW; Lee JH; Lee HC; Kim KJ; Chun WJ; Seo WW; Park WJ; Park SM; Kim JW; Kim HS Circ Cardiovasc Interv; 2024 Jul; 17(7):e013585. PubMed ID: 38786579 [TBL] [Abstract][Full Text] [Related]
10. Comparison of Ultrathin, Bioresorbable-Polymer Sirolimus-Eluting Stents and Thin, Durable-Polymer Everolimus-Eluting Stents in Calcified or Small Vessel Lesions. Dan K; Garcia-Garcia HM; Kolm P; Windecker S; Saito S; Kandzari DE; Waksman R Circ Cardiovasc Interv; 2020 Sep; 13(9):e009189. PubMed ID: 32895004 [TBL] [Abstract][Full Text] [Related]
11. Five-Year Outcomes in Patients With Diabetes Mellitus Treated With Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents. Iglesias JF; Heg D; Roffi M; Tüller D; Lanz J; Rigamonti F; Muller O; Moarof I; Cook S; Weilenmann D; Kaiser C; Cuculi F; Valgimigli M; Jüni P; Windecker S; Pilgrim T J Am Heart Assoc; 2019 Nov; 8(22):e013607. PubMed ID: 31696762 [TBL] [Abstract][Full Text] [Related]
16. Biodegradable Polymer Biolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With Coronary Artery Disease: Final 5-Year Report From the COMPARE II Trial (Abluminal Biodegradable Polymer Biolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent). Vlachojannis GJ; Smits PC; Hofma SH; Togni M; Vázquez N; Valdés M; Voudris V; Slagboom T; Goy JJ; den Heijer P; van der Ent M JACC Cardiovasc Interv; 2017 Jun; 10(12):1215-1221. PubMed ID: 28579236 [TBL] [Abstract][Full Text] [Related]
17. Thin, Very Thin, or Ultrathin Strut Biodegradable or Durable Polymer-Coated Drug-Eluting Stents: 3-Year Outcomes of BIO-RESORT. Buiten RA; Ploumen EH; Zocca P; Doggen CJM; Danse PW; Schotborgh CE; Scholte M; van Houwelingen KG; Stoel MG; Hartmann M; Tjon Joe Gin RM; Somi S; Linssen GCM; Kok MM; von Birgelen C JACC Cardiovasc Interv; 2019 Sep; 12(17):1650-1660. PubMed ID: 31422087 [TBL] [Abstract][Full Text] [Related]
18. Ultrathin bioresorbable polymer sirolimus-eluting stents in US patients undergoing coronary revascularization: 1-Year outcomes from the BIOFLOW VII trial. Kandzari DE; Garcia-Garcia HM; Stoler RC; Wang J; Picone M; Ben-Dor I; Garcia SA Catheter Cardiovasc Interv; 2023 Sep; 102(3):464-471. PubMed ID: 37493431 [TBL] [Abstract][Full Text] [Related]
19. Complex primary percutaneous coronary intervention with ultrathin-strut biodegradable versus thin-strut durable polymer drug-eluting stents in patients with ST-segment elevation myocardial infarction: A subgroup analysis from the BIOSTEMI randomized trial. Iglesias JF; Muller O; Losdat S; Roffi M; Kurz DJ; Weilenmann D; Kaiser C; Heg D; Windecker S; Pilgrim T Catheter Cardiovasc Interv; 2023 Mar; 101(4):687-700. PubMed ID: 36807456 [TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes three-year after revascularization with biodegradable polymer stents: ultrathin-strut sirolimus-eluting stent versus biolimus-eluting stent: from the Scandinavian organization for randomized trials with clinical outcome VII trial. Ellert J; Maeng M; Raungaard B; Hansen KN; Kahlert J; Jensen SE; Bøtker HE; Hansen HS; Lassen JF; Christiansen EH; Jensen LO Coron Artery Dis; 2020 Sep; 31(6):485-492. PubMed ID: 32271243 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]